Synthesis of long nucleic acid sequences

US11034989B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11034989-B2
Application numberUS-201715591783-A
CountryUS
Kind codeB2
Filing dateMay 10, 2017
Priority dateJan 16, 2012
Publication dateJun 15, 2021
Grant dateJun 15, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides methods for the synthesis of long oligonucleotides, genes and gene fragments. The methods include the manufacture of genes or gene fragments that can be then inserted into a variety of vectors.

First claim

Opening claim text (preview).

What is claimed is: 1. A gene fragment library, said library comprising: a plurality of non-vector synthetic nucleic acid gene fragments wherein two or more of the gene fragments are comprised of a constant gene block a of at least 100 bases and a variable gene block of at least 50 bases, wherein the constant gene block sequence is identical for each of the gene fragments and the variable gene block sequence varies, and wherein the plurality of non-vector synthetic nucleic acid gene fragments are chemically synthesized. 2. The gene fragment library of claim 1 wherein the gene fragments further comprise constant gene block b . 3. The gene fragment library of claim 2 wherein the variable gene block is flanked by constant gene block a and constant gene block b . 4. The gene fragment library of claim 2 wherein the gene fragments further comprise constant gene block n wherein n represents a plurality of sets of constant gene blocks. 5. The gene fragment library of claim 1 wherein the gene fragments further comprise variable gene block n wherein n represents a plurality of sets of variable gene blocks. 6. The gene fragment library of claim 1 wherein the gene fragments are at least 400 bases. 7. The gene fragment library of claim 1 wherein the gene fragments are at least 1000 bases. 8. The gene fragment library of claim 3 wherein the constant gene blocks located on terminal ends contain a binding site for a forward primer on a first gene block located at a first terminal end and a reverse amplification primer on a second gene block located at a second terminal end. 9. The gene fragment library of claim 1 wherein the constant gene blocks and the variable gene blocks contain overlap regions for assembly into a gene fragment. 10. The gene fragment library of claim 9 wherein the overlap regions contain a same sequence of complementarity that allow for assembly with universal primers.

Assignees

Inventors

Classifications

  • C12P19/34Primary

    Polynucleotides, e.g. nucleic acids, oligoribonucleotides · CPC title

  • Nucleotides · CPC title

  • Solid-phase processes · CPC title

  • Template (nucleic acid) mediated chemical library synthesis, e.g. chemical and enzymatical DNA-templated organic molecule synthesis, libraries prepared by non ribosomal polypeptide synthesis [NRPS], DNA/RNA-polymerase mediated polypeptide synthesis · CPC title

  • Nucleic acid amplification reactions · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11034989B2 cover?
The invention provides methods for the synthesis of long oligonucleotides, genes and gene fragments. The methods include the manufacture of genes or gene fragments that can be then inserted into a variety of vectors.
Who is the assignee on this patent?
Integrated Dna Tech Inc
What technology area does this patent fall under?
Primary CPC classification C12P19/34. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).